Marcelin Clément, D'Souza Stephen, Le Bras Yann, Petitpierre Francois, Grenier Nicolas, van den Berg Jos C, Huasen Bella
Interventional Radiology, Service d'Imagerie Diagnostique et Thérapeutique de l'Adulte, Hôpital Pellegrin, Place Amélie-Raba-Léon, Bordeaux 33076, France.
Endovascular Unit, Royal Preston Hospital, Lancashire University Teaching Health Trust, Preston, United Kingdom.
J Vasc Interv Radiol. 2018 Jul;29(7):993-997. doi: 10.1016/j.jvir.2018.02.030. Epub 2018 May 30.
To prospectively analyze technical and clinical outcome of percutaneous thrombectomy aspiration using a vacuum-assisted thrombectomy catheter in acutely thrombosed dialysis arteriovenous fistula (AVF) and/or arteriovenous graft (AVG).
From June 2016 to April 2017, 35 patients (average age, 61.8 y; range, 33-81 y) presenting with acute thrombosis of dialysis AVF and/or AVG were prospectively evaluated for mechanical thrombectomy using the Indigo System. Adjunctive therapies and procedure-related complications were noted. Technical success, clinical success, primary patency, primary assisted patency, and secondary patency of the dialysis fistula were assessed.
Mean follow-up time was 8.5 months (range, 3-12 months). Technical success was 97.1% (34/35 patients). Clinical success was 91.4% (32/35 patients). Complications included hematoma (n = 1), thrombosis < 24 hours (n = 1), and perforation (n = 1). Other mechanical/aspiration thrombectomy devices were used in 1 site to clear the thrombus burden (Arrow-Trerotola [2.8%; 1/35 patients] and Fogarty [5.7%; 2/35 patients]). Average procedure time was 38.1 minutes (range, 15-140 min). Average blood loss during the procedure was 122.5 mL (range, 50-300 mL). The 6-month primary patency, primary assisted patency, and secondary patency were 71%, 80%, and 88.5%. No risk factors for early dialysis fistula occlusion were identified. There was no 30-day mortality.
Percutaneous mechanical thrombectomy aspiration of thrombosed dialysis AVF and/or AVG with a vacuum-assisted thrombectomy catheter is a safe procedure with a low complication rate and effective method for restoring patency before hemodialysis.
前瞻性分析使用真空辅助血栓清除导管对急性血栓形成的透析动静脉内瘘(AVF)和/或动静脉移植物(AVG)进行经皮血栓清除抽吸术的技术和临床结果。
2016年6月至2017年4月,对35例(平均年龄61.8岁;范围33 - 81岁)出现透析AVF和/或AVG急性血栓形成的患者,前瞻性地评估使用Indigo系统进行机械血栓清除术。记录辅助治疗和与手术相关的并发症。评估透析内瘘的技术成功率、临床成功率、初次通畅率、初次辅助通畅率和二次通畅率。
平均随访时间为8.5个月(范围3 - 12个月)。技术成功率为97.1%(34/35例患者)。临床成功率为91.4%(32/35例患者)。并发症包括血肿(n = 1)、24小时内血栓形成(n = 1)和穿孔(n = 1)。在1个部位使用了其他机械/抽吸血栓清除装置来清除血栓负荷(Arrow-Trerotola [2.8%;1/35例患者]和Fogarty [5.7%;2/35例患者])。平均手术时间为38.1分钟(范围15 - 140分钟)。手术期间平均失血量为122.5 mL(范围50 - 300 mL)。6个月时的初次通畅率、初次辅助通畅率和二次通畅率分别为71%、80%和88.5%。未发现早期透析内瘘闭塞的危险因素。无30天死亡率。
使用真空辅助血栓清除导管对血栓形成的透析AVF和/或AVG进行经皮机械血栓清除抽吸术是一种安全的手术,并发症发生率低,是血液透析前恢复通畅的有效方法。